These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19331800)

  • 41. [Orphanin FQ combined with adriamycin reverses multi-drug resistance of K562/ADM and its molecular mechanism].
    Wang XX; Liu XQ; Zhang W; Chen X; Zhao L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):574-8. PubMed ID: 22739158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of adriamycin on Gfi-1 expression in K562 cells and its relationship with the relevant apoptotic genes].
    Chang W; Sun HY; Huang M; Zhou JF; Zhang YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):278-82. PubMed ID: 17493331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Synergistic reversal effect of Chinese medicine compound FFJZ combined with cyclosporine A on multidrug resistance of leukemia K562/VCR cell line].
    Liao B; Ge RY; Chen X; Huangfu ZP; Qi Y; Song YP; Wei XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):752-5. PubMed ID: 17708797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
    Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
    Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
    Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Reversal Effect of Dihydromyricetin on Drug Resistance of K562/A02 Cell Line to Adriamycin].
    Li BR; Wang L; Han WN; Xia LQ; Tang S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1369-1374. PubMed ID: 27784359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells.
    Ando T; Nishimura M; Oka Y
    Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting glycometabolic reprogramming to restore the sensitivity of leukemia drug-resistant K562/ADM cells to adriamycin.
    Zhang X; Chen J; Ai Z; Zhang Z; Lin L; Wei H
    Life Sci; 2018 Dec; 215():1-10. PubMed ID: 30473023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Reversal of adriamycin resistance of hepatocellular carcinoma by targeting it with recombined adenovirus carrying antisense multidrug resistance gene 1 RNA].
    Mei Y; Shi YJ; Ding X; Wu CX; Jian HG; Gong JP; Liu CA
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):199-203. PubMed ID: 17407711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line.
    Li WD; Zhang BD; Wei R; Liu JH; Lin ZB
    Acta Pharmacol Sin; 2008 May; 29(5):620-7. PubMed ID: 18430371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of phorbol 12-myristate 13-acetate on function and gene expression of P-glycoprotein in adriamycin-resistant K562/ADM cells.
    Li Y; Bi H; Zhong G; Huang L; Li G; Xia Y; Chen X; Huang M
    Pharmacology; 2013; 92(3-4):121-30. PubMed ID: 24008321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The relationship between multi-drug resistance and proportion of leukemia stem cells and expression of drug transporters in drug-resistant leukemia K562/ADM cells].
    Yi J; Chen J; Sun J; Wei HL
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1741-4. PubMed ID: 19862976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of hypoxia inducible factor1-α inhibitor on reversal of multidrug resistance of K562/A02 cell line].
    Chen BA; Wang F; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Xia GH; Shan XY
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):389-93. PubMed ID: 21122354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trial.
    Liu JZ; Chen SG; Zhang B; Wang CB; Zhao XW; Li GY; Wang LX
    J Altern Complement Med; 2009 Oct; 15(10):1127-30. PubMed ID: 19821717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells.
    Ohtani H; Ikegawa T; Honda Y; Kohyama N; Morimoto S; Shoyama Y; Juichi M; Naito M; Tsuruo T; Sawada Y
    Pharm Res; 2007 Oct; 24(10):1936-43. PubMed ID: 17492365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line.
    Le Moyec L; Tatoud R; Degeorges A; Calabresse C; Bauza G; Eugène M; Calvo F
    Cancer Res; 1996 Aug; 56(15):3461-7. PubMed ID: 8758912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-cancer effects of deguelin on human leukemia K562 and K562/ADM cells In Vitro.
    Wu Q; Chen Y; Liu H; He J
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):149-52. PubMed ID: 17497282
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Knockdown of Alox5 gene promotes apoptosis of K562/ADM cells].
    Luo Y; Xu M; Gao W; Tao K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1398-1403. PubMed ID: 29169426
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D.
    Kurosawa K; Takahashi K; Tsuda E; Tomida A; Tsuruo T
    Jpn J Cancer Res; 2001 Nov; 92(11):1235-41. PubMed ID: 11714449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.